Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
29.08.23
/
50%
€35.09
Target price
29.08.24
€59.70
Performance (%)
-41.89%
Price
30.05.24
€20.39
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc is performing very badly with a performance of -41.89%. This prediction currently runs until 29.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -11.425% | -11.425% |
iShares Core DAX® | -0.530% | 2.858% |
iShares Nasdaq 100 | -0.580% | 4.871% |
iShares Nikkei 225® | -1.097% | -1.658% |
iShares S&P 500 | -0.730% | 2.647% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-40.26%
30.05.24
30.05.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-44.94%
30.05.24
30.05.24